113 related articles for article (PubMed ID: 3786256)
1. Postradiation biopsy and histological effects in early-stage prostatic cancer treated with 125iodine implants.
Kandzari SJ; Riley RS; Belis JA; Jain PR
Prostate; 1986; 9(4):319-26. PubMed ID: 3786256
[TBL] [Abstract][Full Text] [Related]
2. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
[TBL] [Abstract][Full Text] [Related]
3. Iodine-125 implants for carcinoma of the prostate.
Peschel RE; Fogel TD; Kacinski BM; Kelly K; Mate TP
Int J Radiat Oncol Biol Phys; 1985 Oct; 11(10):1777-81. PubMed ID: 4044340
[TBL] [Abstract][Full Text] [Related]
4. Prostate biopsy after definitive treatment by interstitial 125iodine implant or external beam radiation therapy.
Schellhammer PF; el-Mahdi AM; Higgins EM; Schultheiss TE; Ladaga LE; Babb TJ
J Urol; 1987 May; 137(5):897-901. PubMed ID: 3106654
[TBL] [Abstract][Full Text] [Related]
5. [Histological follow-up after implantation of grains of I-125 for prostatic cancer].
Nadalini VF; Giglio C; Bruttini G; Positano N; Fassone M; Fasce L; Medica M; de Angelis P; Fantacci O; Scarpati D; Ledda S
J Urol (Paris); 1983; 89(3):187-190. PubMed ID: 6875299
[TBL] [Abstract][Full Text] [Related]
6. Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer.
Prestidge BR; Hoak DC; Grimm PD; Ragde H; Cavanagh W; Blasko JC
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):31-9. PubMed ID: 9054874
[TBL] [Abstract][Full Text] [Related]
7. Morbidity and mortality of local failure after definitive therapy for prostate cancer.
Schellhammer PF; Whitmore RB; Kuban DA; el-Mahdi AM; Ladaga LA
J Urol; 1989 Mar; 141(3):567-71. PubMed ID: 2918594
[TBL] [Abstract][Full Text] [Related]
8. Iodine 125 seed implants for prostatic carcinoma. Five- and ten-year follow-up.
Weyrich TP; Kandzari SJ; Jain PR
Urology; 1993 Feb; 41(2):122-6. PubMed ID: 8497980
[TBL] [Abstract][Full Text] [Related]
9. Histological characteristics of prostatic biopsies after 125iodine implantation.
Schellhammer PF; Ladaga LE; El-Mahdi A
J Urol; 1980 May; 123(5):700-5. PubMed ID: 7420559
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer.
Zelefsky MJ; Whitmore WF
J Urol; 1997 Jul; 158(1):23-9; discussion 29-30. PubMed ID: 9186315
[TBL] [Abstract][Full Text] [Related]
11. 125Iodine implantation after lymphadenectomy in early carcinoma of the prostate.
Giles GM; Brady LW
Int J Radiat Oncol Biol Phys; 1986 Dec; 12(12):2117-25. PubMed ID: 3793548
[TBL] [Abstract][Full Text] [Related]
12. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
[TBL] [Abstract][Full Text] [Related]
13. Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer.
Merrick GS; Butler WM; Galbreath RW; Lief JH
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):41-8. PubMed ID: 11516849
[TBL] [Abstract][Full Text] [Related]
14. Failure of open radioactive 125iodine implantation to control localized prostate cancer: a study of 41 patients.
Gottesman JE; Tesh DG; Weissman WD
J Urol; 1991 Nov; 146(5):1317-9; discussion 1319-20. PubMed ID: 1942283
[TBL] [Abstract][Full Text] [Related]
15. Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate.
Perez CA; Michalski J; Brown KC; Lockett MA
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):573-84. PubMed ID: 8948341
[TBL] [Abstract][Full Text] [Related]
16. Preliminary observations on the results of combined 125iodine seed implantation and external irradiation for carcinoma of the prostate.
Ross G; Borkon WD; Landry LJ; Edwards FM; Weinstein SH; Abadir R
J Urol; 1982 Apr; 127(4):699-701. PubMed ID: 7069833
[TBL] [Abstract][Full Text] [Related]
17. The treatment of choice for localized poorly differentiated adenocarcinoma of the prostate.
el-Mahdi AM; Kuban DA; Schellhammer PF
Am J Clin Oncol; 1985 Dec; 8(6):477-80. PubMed ID: 4083266
[TBL] [Abstract][Full Text] [Related]
18. Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation.
Stromberg J; Martinez A; Benson R; Garton G; Diokno A; Gonzalez J; Zincke H; Schray M; Edmundson G; Brabbins D
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):67-75. PubMed ID: 8270460
[TBL] [Abstract][Full Text] [Related]
19. Preoperative irradiation, lymphadenectomy, and 125iodine implantation for patients with localized carcinoma of the prostate.
DeLaney TF; Shipley WU; O'Leary MP; Biggs PJ; Prout GR
Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1779-85. PubMed ID: 3759530
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma of the prostate irradiated by combined I125 and external irradiation. Analysis of failure and significance of positive biopsy one year or more after therapy.
Abadir R; Ross G; Weinstein SH
Int J Radiat Oncol Biol Phys; 1983 Mar; 9(3):305-9. PubMed ID: 6841182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
